Jaguar Health (JAGX) Payables (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Payables of $27.0 million for Q1 2026, up 5.34% year-over-year from $25.7 million in Q1 2025, and down 25.17% quarter-over-quarter from $36.1 million in Q4 2025.
Jaguar Health (JAGX) Payables (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Payables for 13 consecutive years, with $27.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 5.34% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $27.0 million (up 5.34% YoY), while the FY2025 annual figure was $36.1 million, up 108.53% from the prior year.
- Payables declined to $27.0 million in Q1 2026 per JAGX's latest filing, from $36.1 million in the prior quarter.
- Across five years, Payables topped out at $36.1 million in Q4 2025 and bottomed at $8.6 million in Q3 2023.
- Historically, Payables has averaged $19.4 million across 5 years, with a median of $18.0 million in 2022.
- Annual changes were most pronounced in 2022 — Payables soared 223.73% — and 2023, when it sank 54.63%.
- Jaguar Health's Payables stood at $21.7 million in 2022, then tumbled by 54.63% to $9.8 million in 2023, then surged by 76.04% to $17.3 million in 2024, then surged by 108.53% to $36.1 million in 2025, then retreated by 25.17% to $27.0 million in 2026.
- Business Quant data shows JAGX's Payables at $27.0 million in Q1 2026, $36.1 million in Q4 2025, and $31.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 35.57 Mn |
| 10 | Jaguar Health | 440,895.58 | -9.62 Mn | 19.11 Mn | 27.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.03 Mn |
| Dec 31, 2025 | 36.13 Mn |
| Sep 30, 2025 | 31.55 Mn |
| Jun 30, 2025 | 25.19 Mn |
| Mar 31, 2025 | 25.66 Mn |
| Dec 31, 2024 | 17.32 Mn |
| Sep 30, 2024 | 16.04 Mn |
| Jun 30, 2024 | 15.21 Mn |
| Mar 31, 2024 | 13.71 Mn |
| Dec 31, 2023 | 9.84 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 18.47 Mn |
| Mar 31, 2023 | 21.31 Mn |
| Dec 31, 2022 | 21.69 Mn |
| Sep 30, 2022 | 18.02 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Mar 31, 2022 | 10.60 Mn |
| Dec 31, 2021 | 8.11 Mn |
| Sep 30, 2021 | 5.57 Mn |
| Jun 30, 2021 | 6.06 Mn |